You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 809 A bispecific antibody targeting CCR8 & CTLA-4: Potent anti-tumor efficacy with better safety by preferentially eliminating tumor-infiltrating regulatory T cells

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
809 A bispecific antibody targeting CCR8 & CTLA-4: Potent anti-tumor efficacy with better safety by preferentially eliminating tumor-infiltrating regulatory T cells

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023132017
Dec 20236009
Jan 20246706
Feb 20244008
Mar 202466018
Apr 202440048
May 202446018
Jun 202418020
Jul 202430029
Aug 20241607
Sep 202436014
Oct 202458029
Nov 202436022
Dec 202420012
Jan 202538020
Feb 202511024
Mar 20250017
Apr 20250012
May 20250011
Jun 20250011
Total7140352